Spero Therapeutics, Inc. (NASDAQ:SPRO) Sees Large Decline in Short Interest
Spero Therapeutics, Inc. (NASDAQ:SPRO - Get Free Report) was the target of a large decrease in short interest in February. As of February 27th, there was short interest totaling 574,027 shares, a...